Drug recall · October 1, 2014
Olanzapine Orally Disintegrating Tablets 5 mg recall
Why: Subpotent Drug: Out of specification (OOS) results at the 9 month temperature point.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Olanzapine Orally Disintegrating Tablets 5 mg, 30-count Bottle, Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada M9L1T9, Manufactured for Apotex Corp., Weston, Florida 33326, NDC # 60505-3275-03
- Lots / codes
Lot # KM4951; Exp. 04/15
- Quantity
- 5,397 bottles
- Company
- Apotex Corp., Weston, FL
- Distribution
- Nationwide.
- Initiated
- April 18, 2014 · Voluntary: Firm initiated
- Classified
- September 24, 2014
- Reported
- October 1, 2014
- Ended
- April 7, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Olanzapine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.